An Update on the Reversal of Non-Vitamin K Antagonist Oral Anticoagulants

Non-vitamin K antagonist oral anticoagulants (NOACs) include thrombin inhibitor dabigatran and coagulation factor Xa inhibitors rivaroxaban, apixaban, edoxaban, and betrixaban. NOACs have several benefits over warfarin, including faster time to the achieve effect, rapid onset of action, fewer docume...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Adv Hematol
Päätekijät: Mujer, Mark Terence P., Rai, Manoj P., Atti, Varunsiri, Dimaandal, Ian Limuel, Chan, Abigail S., Shrotriya, Shiva, Gundabolu, Krishna, Dhakal, Prajwal
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Hindawi 2020
Aiheet:
Review Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7097770/
https://ncbi.nlm.nih.gov/pubmed/32231703
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/7636104
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia